BIOTECH (99) BlueRock Therapeutics: Bemdaneprocel (BRT-DA01, MSK-DA01) – Autologous Stem Cell Therapy for Parkinson’s Disease March 1, 2024March 1, 2024
BIOTECH (98) Basking Biosciences: Bruce Sullenger’s Reversable RNA Aptamer Platform March 1, 2024March 1, 2024
BIOTECH (97) Tome Biosciences: Programmable Genomic Integration (PGI) Platform February 29, 2024February 29, 2024
BIOTECH (96) – Janux Therapeutics: Tumor Activated Masked T-Cell Engager (TRACTr) Platform February 29, 2024
BIOTECH (95) – Ikena Oncology – Rebranding and Restructuring from Discovery to Clinical Focus February 23, 2024February 23, 2024
BIOTECH (94) – Inventiva Pharma: Lanifibranor, a pan-PPAR agonist MASH 치료제 NATIV Phase 3 February 22, 2024February 22, 2024